Search All News
Columbia Psychiatry's Caroline Arout uses quantitative sensory testing, or QST, for assessing the effectiveness of cannabis for therapeutic uses.
Dr. Sidney Hankerson is one of 10 scholars named as 2021’s Emerging Leaders in Health and Medicine by the National Academy of Medicine (NAM).
Ravi N. Shah, MD has been named Chief Innovation Officer for Columbia Psychiatry.
Source:MedscapeDecember 15, 2020
"[Buprenorphine] is a tremendously powerful medication, saves many lives and prevents overdose, but there is a risk of misuse and diversion, albeit pretty low," says Dr. Francis Levin.
Source:STAT NewsDecember 9, 2020
Lack of contact and comfort from other people can slow the acceptance of the reality and meaning of a loss, and keep the intensity of grief “profound and at center stage,” Dr. Katherine Shear said.
Source:StatDecember 8, 2020
"The number one goal of health tech, unlike other tech, is not to engage and immerse patients in their phones but to support and embolden them in their real lives," writes Dr. Ravi Shah.
Source:Washington PostDecember 6, 2020
Among those on high doses of steroid medications, "between 5 and 18 percent experience significant “mental status changes,” as we call them," writes Dr. Sally Satel.
Source:Psychiatric TimesDecember 2, 2020
Dr. Joshua Kantrowitz discusses a recent trial of CVN058, a drug that may reduce cognitive impairments in individuals with schizophrenia.
Source:Hello GigglesDecember 2, 2020
“Many people have preconceived notions about antidepressants some of which are based on the unfortunate stigma with mental health,” says Dr. Diana Samuel.
- November 30, 2020
"Our guidance emphasizes the importance of building resilience in families. We should instead focus on “what’s strong” and consistently build those factors," said Dr. Evelyn Berger-Jenkins.
Source:Rolling StoneNovember 24, 2020
Bulimia nervosa is an eating disorder characterized by episodes of binge eating followed by compensatory behaviors aimed at preventing weight gain, most commonly vomiting, explains Dr. Evelyn Attia.
- November 16, 2020
The Substance Abuse and Mental Health Services Administration has awarded $32 million to the American Academy of Addiction Psychiatry to address opioid use disorders and stimulant use disorders.